Since our analysis revealed an overexpression of BCL9 in estrogen-receptor positive Lum A cancers, it is possible that BCL9 interacts with proteins other than β-catenin, and its activity may be, in part, independent of Wnt/β-catenin [93]. The gene discussed is ESR1; the disease is cancer.